[{"data":1,"prerenderedAt":326},["ShallowReactive",2],{"content-route-/en/symptoms-conditions/vaginal-yeast-treatment-not-working":3},{"state":4,"owner":4,"route":5,"locale":6,"template":7,"content":14,"projection":117,"alternates":317},"target","/en/symptoms-conditions/vaginal-yeast-treatment-not-working","en-US",{"kind":8,"family":9,"sectionKeys":10},"direct-answer","guidance",[11,12,13],"explanation","alternatives","evidence",{"kind":8,"title":15,"description":16,"firstPublished":17,"evidenceAsOf":17,"lastUpdated":17,"changeNote":18,"firstLayer":19,"relations":49,"body":87},"When vaginal yeast treatment does not work","Learn what no improvement, partial improvement, symptom return, worsening, a treatment reaction, or new symptoms mean—and what to do next without assuming yeast is still the cause.","2026-07-15","Complete initial draft based on the Pathway A orientation, treatment, and US authority packs.",{"question":20,"answer":21,"keyPoints":22,"confidence":26,"applicability":29,"nextSteps":36},"What should I do if vaginal yeast treatment did not work, only partly helped, or the symptoms came back?","No improvement, partial improvement, return, worsening, or new symptoms after treatment do not prove that yeast remains the cause; arrange reassessment instead of automatically repeating or escalating treatment.",[23,24,25],"Keep no improvement, partial improvement, return after improvement, worsening, a treatment reaction, and new symptoms separate because they change what should be reviewed.","Failed presumed-yeast treatment reopens the differential, including another infection, mixed vaginitis, non-albicans Candida, irritation, inflammation, vulvar disease, or a pain condition.","The next option depends on confirmation, examination and testing, pregnancy and immune status, medicines, the exact product used, and the response—not on a personalized online drug ranking.",{"summary":27,"rationale":28},"Strong confidence that persistent, returned, worsened, or changed symptoms need reassessment; the cause and next treatment remain individual.","CDC and ISSVD guidance agree that symptoms overlap across causes and that persistence or early return after treatment calls for clinical evaluation and appropriate testing rather than proof of residual yeast.",{"appliesTo":30,"excludes":33},[31,32],"Adolescents and adults in the United States whose vaginal or vulvar symptoms did not improve, partly improved, returned, worsened, or changed after presumed or diagnosed yeast treatment.","People who had an adverse effect or unexpected symptom while using a vaginal yeast treatment and need to distinguish a product reaction from the original problem.",[34,35],"People with signs of an acute allergic reaction or another medical emergency, who need the urgent route now.","People who are pregnant or might be pregnant, have poorly controlled diabetes or an immunocompromising condition, or take immunosuppressive therapy; clinician review is needed because diagnosis and treatment boundaries differ.",[37,41,45],{"label":38,"action":39,"route":40},"Arrange reassessment","If symptoms persisted after over-the-counter treatment, returned within two months, or continued or recurred after prescribed treatment, arrange a clinician visit for evaluation and testing instead of repeating self-treatment.","/en/tools/treatment-history",{"label":42,"action":43,"route":44},"Reopen the possible causes","Review the meaningful infectious and noninfectious alternatives that can resemble yeast symptoms, without using the list to diagnose yourself.","/en/symptoms-conditions/vaginal-yeast-infection-lookalikes",{"label":46,"action":47,"route":48},"Use urgent help only for an observable trigger","Use the urgent route for an acute product reaction, immediate danger, or an acute emotional crisis; treatment failure by itself is not a crisis trigger.","/en/urgent-help",[50,54,57,61,64,68,71,75,78,81,84],{"group":51,"route":52,"label":53},"parent","/en/symptoms-conditions/vaginal-yeast-infection","Vaginal symptoms",{"group":55,"route":44,"label":56},"differential","What can look like a vaginal yeast infection",{"group":58,"route":59,"label":60},"treatment","/en/treatments-evidence/vaginal-yeast-treatment","Vaginal yeast treatment",{"group":58,"route":62,"label":63},"/en/treatments-evidence/topical-vs-oral-vaginal-yeast-treatment","Topical vs oral vaginal yeast treatment",{"group":65,"route":66,"label":67},"recurrenceFailure","/en/symptoms-conditions/recurrent-vaginal-yeast-infection","Recurrent vaginal symptoms",{"group":13,"route":69,"label":70},"/en/research/evidence/recurrent-vaginal-yeast-symptoms","Evidence map for recurrent vaginal yeast symptoms",{"group":72,"route":73,"label":74},"research","/en/research/rvvc-diagnostic-experiences-2026","Study summary on RVVC diagnostic experiences",{"group":72,"route":76,"label":77},"/en/research/rvvc-quality-of-life-2019","Study summary on RVVC and quality of life",{"group":79,"route":40,"label":80},"tool","Treatment history",{"group":79,"route":82,"label":83},"/en/tools/appointment-planner","Appointment planner",{"group":85,"route":48,"label":86},"safety","Urgent help",{"type":88,"value":89,"toc":113},"minimark",[90,101,107],[91,92,94,98],"content-section",{"section-key":11,"title":93},"Name the response before choosing the next step",[95,96,97],"p",{},"No improvement means the symptoms never meaningfully eased. Partial improvement means some symptoms or their intensity changed but the problem did not resolve. Return means symptoms reappeared after a period of improvement. Worsening means the original symptoms became more severe. An adverse reaction means an unwanted effect appeared while or after using the product; sudden breathing difficulty, wheezing, facial or mouth swelling, hives, blistering, or skin peeling while taking the exact Greenstone fluconazole products covered by the current US label requires emergency care. New symptoms mean the symptom pattern changed rather than simply persisted. None of these states proves residual yeast, and worsening or a reaction should not be interpreted as healing. Record the product, timing, completion, adverse effects, prior tests, and exactly what improved, persisted, returned, worsened, or appeared.",[95,99,100],{},"Treatment failure can be exhausting, but it does not by itself call for a crisis banner. If someone says they are thinking about suicide, cannot stay safe, or is in acute emotional crisis, call or text 988 or use 988 Lifeline chat now; call 911 or go to an emergency room for immediate danger or a medical emergency. That support is paired with the constructive next step of reassessment and a clear treatment history.",[91,102,104],{"section-key":12,"title":103},"Why the possible cause must be reopened",[95,105,106],{},"Symptoms attributed to yeast can instead reflect bacterial vaginosis, trichomoniasis, cervicitis, irritation, inflammation, vulvar disease, or a pain condition. Mixed vaginitis can involve more than one process, and non-albicans Candida or another species-level question can matter in persistent presentations. The purpose of reassessment is not to rank these possibilities online. It is to match examination and testing to the changed symptom pattern, then choose treatment only after the problem is clearer.",[91,108,110],{"section-key":13,"title":109},"Evidence and sources",[95,111,112],{},"The linked evidence map traces the reassessment, differential, treatment-history, burden, and targeted-crisis boundaries to their exact claims, populations, limitations, original sources, and research summaries. This page remains a draft until its planned evidence-map and treatment-history records are available for publication.",{"title":114,"searchDepth":115,"depth":115,"links":116},"",2,[],{"sources":118,"claims":190,"safety":254},[119,127,131,138,146,153,160,168,176,184],{"sourceId":120,"title":121,"canonicalId":122,"canonicalUrl":123,"publisher":124,"sourceType":125,"publicationDate":126,"lastChecked":17},"cdc-sti-vvc-2021","Sexually Transmitted Infections Treatment Guidelines, 2021: Vulvovaginal Candidiasis","doi:10.15585/mmwr.rr7004a1","https://www.cdc.gov/std/treatment-guidelines/candidiasis.htm","US Centers for Disease Control and Prevention","guideline","2021-07-23",{"sourceId":128,"title":129,"canonicalId":122,"canonicalUrl":130,"publisher":124,"sourceType":125,"publicationDate":126,"lastChecked":17},"cdc-sti-vaginal-discharge-2021","Sexually Transmitted Infections Treatment Guidelines, 2021: Diseases Characterized by Vulvovaginal Itching, Burning, Irritation, Odor or Discharge","https://www.cdc.gov/std/treatment-guidelines/vaginal-discharge.htm",{"sourceId":132,"title":133,"canonicalId":134,"canonicalUrl":135,"publisher":136,"sourceType":125,"publicationDate":137,"lastChecked":17},"issvd-vaginitis-recommendations-2023","International Society for the Study of Vulvovaginal Disease Recommendations for the Diagnosis and Treatment of Vaginitis","doi:10.59153/adm.rdtv.001","https://www.issvd.org/resources/recommendations-for-the-diagnosis-and-treatment-of-vaginitis","International Society for the Study of Vulvovaginal Disease","2023-03-01",{"sourceId":139,"title":140,"canonicalId":141,"canonicalUrl":142,"publisher":143,"sourceType":144,"publicationDate":145,"lastChecked":17},"ford-rvvc-diagnostic-experiences-2026","It's not just thrush, it's recurrent thrush: a qualitative study of patient and clinician perspectives on diagnosing recurrent vulvovaginal candidiasis","doi:10.3399/BJGP.2025.0437","https://pubmed.ncbi.nlm.nih.gov/41628983/","British Journal of General Practice","observational-study","2026-06-01",{"sourceId":147,"title":148,"canonicalId":149,"canonicalUrl":150,"publisher":151,"sourceType":144,"publicationDate":152,"lastChecked":17},"aballea-rvvc-quality-of-life-2013","Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidosis in Europe and the USA","doi:10.1186/1477-7525-11-169","https://pubmed.ncbi.nlm.nih.gov/24119427/","Health and Quality of Life Outcomes","2013-10-11",{"sourceId":154,"title":155,"canonicalId":156,"canonicalUrl":157,"publisher":158,"sourceType":144,"publicationDate":159,"lastChecked":17},"fukazawa-rvvc-quality-of-life-2019","Influence of recurrent vulvovaginal candidiasis on quality of life issues","doi:10.1007/s00404-019-05228-3","https://pubmed.ncbi.nlm.nih.gov/31270690/","Archives of Gynecology and Obstetrics","2019-07-03",{"sourceId":161,"title":162,"canonicalId":163,"canonicalUrl":164,"publisher":165,"sourceType":166,"publicationDate":167,"lastChecked":17},"psychosocial-recurrent-urogenital-review-2023","Psychosocial impact of recurrent urogenital infections: a review","doi:10.1177/17455057231216537","https://pubmed.ncbi.nlm.nih.gov/38099456/","SAGE Publications","other","2023-01-01",{"sourceId":169,"title":170,"canonicalId":171,"canonicalUrl":172,"publisher":173,"sourceType":174,"publicationDate":175,"lastChecked":17},"owh-vaginal-yeast-infections-2025","Vaginal yeast infections","Office on Women's Health health topic: vaginal yeast infections","https://womenshealth.gov/a-z-topics/vaginal-yeast-infections","Office on Women's Health, U.S. Department of Health and Human Services","official-care-service","2025-10-24",{"sourceId":177,"title":178,"canonicalId":179,"canonicalUrl":180,"publisher":181,"sourceType":182,"publicationDate":183,"lastChecked":17},"dailymed-fluconazole-greenstone-2026","FLUCONAZOLE tablet; FLUCONAZOLE powder, for suspension","DailyMed setid 737e0fac-a2d2-4053-a0d7-edbfb6248f69","https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=737e0fac-a2d2-4053-a0d7-edbfb6248f69","U.S. National Library of Medicine DailyMed; labeler Greenstone LLC","official-product","2026-04-02",{"sourceId":185,"title":186,"canonicalId":187,"canonicalUrl":188,"publisher":186,"sourceType":174,"publicationDate":189,"lastChecked":17},"988-lifeline-us-2022","988 Suicide & Crisis Lifeline","US three-digit crisis service 988","https://988lifeline.org/","2022-07-16",[191,206,218,229,240],{"claimId":192,"exactClaim":193,"outcome":194,"population":195,"verdict":196,"evidenceLevel":197,"rationale":198,"safetyStatus":199,"evidenceAsOf":17,"lastUpdated":17,"status":200,"changeHistory":201,"sources":202},"persistent-returned-vaginal-symptoms-require-reassessment","No improvement, only partial improvement, symptom return after treatment, worsening, or new vulvovaginal symptoms do not confirm residual yeast; they change the situation to unresolved symptoms that require reassessment of the diagnosis and appropriate testing.","recognition of treatment nonresponse or recurrence as diagnostic reassessment states rather than proof of ongoing candidiasis","adolescents and adults with suspected or previously diagnosed vulvovaginal candidiasis whose symptoms do not fully resolve, return, worsen, or change after treatment","supported","moderate","CDC requires clinical evaluation and testing for persistent symptoms after over-the-counter treatment or recurrence within two months and follow-up for persistent or recurrent symptoms. ISSVD emphasizes culture and exclusion of other causes in complicated or persistent presentations. The exact urgency attached to worsening or new observable symptoms remains locale-safety owned.","usual-cautions","active",[],[203,204,205],{"title":121,"canonicalId":122,"canonicalUrl":123,"publisher":124,"sourceType":125,"publicationDate":126,"lastChecked":17},{"title":129,"canonicalId":122,"canonicalUrl":130,"publisher":124,"sourceType":125,"publicationDate":126,"lastChecked":17},{"title":133,"canonicalId":134,"canonicalUrl":135,"publisher":136,"sourceType":125,"publicationDate":137,"lastChecked":17},{"claimId":207,"exactClaim":208,"outcome":209,"population":210,"verdict":196,"evidenceLevel":211,"rationale":212,"safetyStatus":199,"evidenceAsOf":17,"lastUpdated":17,"status":200,"changeHistory":213,"sources":214},"failed-vvc-treatment-broadens-differential","When presumed yeast treatment does not resolve symptoms, the differential should be reopened to include bacterial vaginosis, trichomoniasis, cervicitis, mixed vaginitis, non-albicans Candida, and mechanical, chemical, allergic, inflammatory, vulvar, or pain conditions rather than simply repeating the yeast label.","identification of an alternative or coexisting cause after failed empiric vulvovaginal-candidiasis treatment","adolescents and adults with persistent, recurrent, or changed vulvovaginal symptoms after empiric or diagnosis-directed antifungal treatment","strong","CDC identifies BV, trichomoniasis, cervicitis, and noninfectious mechanical, chemical, and allergic causes in the differential and recommends specialist consideration when symptoms remain unexplained. ISSVD additionally addresses mixed vaginitis, inflammatory vaginitis, vulvodynia, vulvar dermatoses, and non-albicans yeast in persistent presentations.",[],[215,216,217],{"title":129,"canonicalId":122,"canonicalUrl":130,"publisher":124,"sourceType":125,"publicationDate":126,"lastChecked":17},{"title":121,"canonicalId":122,"canonicalUrl":123,"publisher":124,"sourceType":125,"publicationDate":126,"lastChecked":17},{"title":133,"canonicalId":134,"canonicalUrl":135,"publisher":136,"sourceType":125,"publicationDate":137,"lastChecked":17},{"claimId":219,"exactClaim":220,"outcome":221,"population":222,"verdict":196,"evidenceLevel":197,"rationale":223,"safetyStatus":199,"evidenceAsOf":17,"lastUpdated":17,"status":200,"changeHistory":224,"sources":225},"structured-vaginal-history-supports-evaluation","Recording symptom timing and pattern, episode count, menstrual context, relevant exposures, prior test results, treatments used, adherence, adverse effects, and response supports evaluation of recurrent or unresolved vulvovaginal symptoms, but the history cannot establish the cause without appropriate examination and testing.","completeness and interpretability of clinical evaluation for recurrence or treatment failure","adolescents and adults preparing for evaluation of recurrent, persistent, or previously treated vulvovaginal symptoms","CDC specifies the history elements relevant to vaginal symptoms while warning that history alone is diagnostically insufficient. ISSVD ties recurrence decisions to episode pattern, testing, species, and treatment response; a 2026 qualitative study describes documentation, test access, and interpretation as parts of the diagnostic pathway but cannot by itself establish outcome benefit from a tool.",[],[226,227,228],{"title":129,"canonicalId":122,"canonicalUrl":130,"publisher":124,"sourceType":125,"publicationDate":126,"lastChecked":17},{"title":133,"canonicalId":134,"canonicalUrl":135,"publisher":136,"sourceType":125,"publicationDate":137,"lastChecked":17},{"title":140,"canonicalId":141,"canonicalUrl":142,"publisher":143,"sourceType":144,"publicationDate":145,"lastChecked":17},{"claimId":230,"exactClaim":231,"outcome":232,"population":233,"verdict":196,"evidenceLevel":197,"rationale":234,"safetyStatus":199,"evidenceAsOf":17,"lastUpdated":17,"status":200,"changeHistory":235,"sources":236},"rvvc-associated-with-quality-of-life-burden","Recurrent vulvovaginal candidiasis is associated with lower physical, psychological, sexual, social, and overall health-related quality of life compared with people without recurrence.","health-related quality of life and psychological distress associated with recurrent vulvovaginal candidiasis","adults with culture-confirmed recurrent vulvovaginal candidiasis or survey-defined four-or-more self-reported yeast episodes in 12 months","Two observational studies using validated quality-of-life instruments in Brazil, Europe, and the United States consistently report lower physical and psychological well-being, with a later narrative review finding the same direction. Cross-sectional and self-reported designs limit causal inference and applicability to every individual.",[],[237,238,239],{"title":148,"canonicalId":149,"canonicalUrl":150,"publisher":151,"sourceType":144,"publicationDate":152,"lastChecked":17},{"title":155,"canonicalId":156,"canonicalUrl":157,"publisher":158,"sourceType":144,"publicationDate":159,"lastChecked":17},{"title":162,"canonicalId":163,"canonicalUrl":164,"publisher":165,"sourceType":166,"publicationDate":167,"lastChecked":17},{"claimId":241,"exactClaim":242,"outcome":243,"population":244,"verdict":245,"evidenceLevel":246,"rationale":247,"safetyStatus":199,"evidenceAsOf":17,"lastUpdated":17,"status":248,"changeHistory":249,"sources":250},"rvvc-alone-does-not-justify-targeted-crisis-routing","Recurrence or failed vulvovaginal-candidiasis treatment, without an observable disclosure or sign of acute psychological danger, is sufficient on its own to identify a person who needs condition-specific crisis routing.","validity of recurrence or antifungal-treatment failure alone as a trigger for targeted crisis intervention","adolescents and adults reporting recurrent vulvovaginal candidiasis, recurrent self-attributed yeast symptoms, or failed yeast treatment","not-enough-evidence","unclear","The identified literature supports group-level quality-of-life, anxiety, depression, and distress burdens but does not validate recurrence or treatment failure alone as a predictor or triage criterion for imminent self-harm. General observable crisis disclosures remain important, but their exact trigger, care action, resource, and expiry belong to locale-authority safety records.","blocked",[],[251,252,253],{"title":148,"canonicalId":149,"canonicalUrl":150,"publisher":151,"sourceType":144,"publicationDate":152,"lastChecked":17},{"title":155,"canonicalId":156,"canonicalUrl":157,"publisher":158,"sourceType":144,"publicationDate":159,"lastChecked":17},{"title":162,"canonicalId":163,"canonicalUrl":164,"publisher":165,"sourceType":166,"publicationDate":167,"lastChecked":17},[255,268,283,295,307],{"safetyId":256,"observableTrigger":257,"careTier":258,"action":259,"applicablePopulations":260,"excludedPopulations":262,"locale":6,"checkedAt":17,"expiresAt":264,"sources":265},"us-vvc-persistent-or-early-return-routine","Vaginal symptoms persist after an over-the-counter yeast treatment, return less than 2 months after treatment, or continue or recur after prescribed treatment.","routine","Arrange a clinician visit for evaluation and testing instead of repeating self-treatment without reassessment.",[261],"adolescents and adults in the United States with vaginal or vulvar symptoms after yeast treatment",[263],"people with a simultaneous medical emergency or acute mental-health crisis, who need the applicable emergency route","2027-01-15",[266,267],{"title":121,"canonicalId":122,"canonicalUrl":123,"publisher":124,"sourceType":125,"publicationDate":126,"lastChecked":17},{"title":170,"canonicalId":171,"canonicalUrl":172,"publisher":173,"sourceType":174,"publicationDate":175,"lastChecked":17},{"safetyId":269,"observableTrigger":270,"careTier":258,"action":271,"applicablePopulations":272,"excludedPopulations":275,"locale":6,"checkedAt":17,"expiresAt":278,"sources":279},"us-vvc-pregnancy-treatment-routine","The person is pregnant, might be pregnant, or becomes pregnant while considering or taking treatment for vaginal yeast symptoms.","Contact the pregnancy-care clinician before self-treating; do not use the exact fluconazole products in DailyMed setid 737e0fac-a2d2-4053-a0d7-edbfb6248f69 unless the clinician directs their use, and report pregnancy during use promptly.",[273,274],"pregnant or possibly pregnant people in the United States with vaginal yeast symptoms","people who become pregnant while taking the exact referenced fluconazole tablet or suspension products",[276,277],"nonpregnant people not planning pregnancy","users of other products whose labels were not checked by this record","2026-10-15",[280,281,282],{"title":121,"canonicalId":122,"canonicalUrl":123,"publisher":124,"sourceType":125,"publicationDate":126,"lastChecked":17},{"title":178,"canonicalId":179,"canonicalUrl":180,"publisher":181,"sourceType":182,"publicationDate":183,"lastChecked":17},{"title":170,"canonicalId":171,"canonicalUrl":172,"publisher":173,"sourceType":174,"publicationDate":175,"lastChecked":17},{"safetyId":284,"observableTrigger":285,"careTier":258,"action":286,"applicablePopulations":287,"excludedPopulations":289,"locale":6,"checkedAt":17,"expiresAt":264,"sources":292},"us-vvc-compromised-host-routine","The person with vaginal yeast symptoms has poorly controlled diabetes, HIV or another immunocompromising condition, an underlying immunodeficiency, or current corticosteroid or other immunosuppressive therapy.","Arrange clinician evaluation rather than relying on a short course of self-treatment, because diagnosis and response may differ in these populations.",[288],"adolescents and adults in the United States with vaginal yeast symptoms and a listed condition or therapy",[290,291],"people without a listed condition or therapy","people with a simultaneous medical emergency, who need emergency care",[293,294],{"title":121,"canonicalId":122,"canonicalUrl":123,"publisher":124,"sourceType":125,"publicationDate":126,"lastChecked":17},{"title":170,"canonicalId":171,"canonicalUrl":172,"publisher":173,"sourceType":174,"publicationDate":175,"lastChecked":17},{"safetyId":296,"observableTrigger":297,"careTier":298,"action":299,"applicablePopulations":300,"excludedPopulations":302,"locale":6,"checkedAt":17,"expiresAt":278,"sources":305},"us-fluconazole-greenstone-allergic-reaction-emergency","While taking the exact fluconazole tablet or suspension products in DailyMed setid 737e0fac-a2d2-4053-a0d7-edbfb6248f69, the person develops shortness of breath, wheezing, swelling of the eyelids, face, mouth, neck, or body, hives, blisters, skin peeling, or another sign of an acute allergic reaction.","emergency","Stop taking that product and go to the nearest hospital emergency room now; call 911 if immediate transport or emergency assistance is needed.",[301],"people in the United States currently taking the exact referenced Greenstone fluconazole tablet or suspension products",[303,304],"users of a different product whose label was not checked by this record","people without an observable sign of an acute allergic reaction",[306],{"title":178,"canonicalId":179,"canonicalUrl":180,"publisher":181,"sourceType":182,"publicationDate":183,"lastChecked":17},{"safetyId":308,"observableTrigger":309,"careTier":298,"action":310,"applicablePopulations":311,"excludedPopulations":313,"locale":6,"checkedAt":17,"expiresAt":278,"sources":315},"us-rvvc-acute-crisis-emergency","A person dealing with recurrent symptoms or treatment failure says they are thinking about suicide, cannot stay safe, or are in acute emotional crisis.","Call or text 988, or use 988 Lifeline chat, now for crisis support; call 911 or go to an emergency room for immediate danger or a medical emergency.",[312],"people in the United States with recurrent vaginal symptoms or vaginal-treatment failure who disclose the observable crisis trigger",[314],"people with recurrence or treatment failure but no observable crisis disclosure or acute danger",[316],{"title":186,"canonicalId":187,"canonicalUrl":188,"publisher":186,"sourceType":174,"publicationDate":189,"lastChecked":17},[318,321,324],{"rel":319,"hreflang":6,"href":320},"alternate","https://candipedia.org/en/symptoms-conditions/vaginal-yeast-treatment-not-working/",{"rel":319,"hreflang":322,"href":323},"pl-PL","https://candipedia.org/pl/objawy-i-problemy/leczenie-grzybicy-pochwy-nie-pomaga/",{"rel":319,"hreflang":325,"href":320},"x-default",1784685064869]